Evelyn Warner, Author at Labiotech.eu

About

Ex-Editor. Recovering organic chemist. Chagrined member of the Brooklyn-Berlin exchange program. Proud parent of a majestic domestic long hair.

Articles by Evelyn Warner

Best in Biotech 27 Dec 2017

The Biggest Biotech News of 2017: What Happened This Year?

Still catching up on news? We’ve picked out the most exciting things that happened besides clinical results and finance. Here’s the biggest biotech news of 2017. We’ve been recapping the year with the most stellar biotechs, most heartening clinical successes and most disappointing failures in biotech. But what else happened this year? There’s more news […]

December 27, 2017 - 3 minutesmins - By Evelyn Warner

Best in Biotech 26 Dec 2017

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

We love hearing from our readers, and we listen to what they like! Here are the long reads from our best biotech articles of 2017. We gave you a list of books to read this holiday season, but do you need something lighter for the post-Christmas daze? We’ve collected our most popular long articles of […]

December 26, 2017 - 6 minutesmins - By Evelyn Warner

More News! 21 Dec 2017

Oxford Biotech Makes a Latin American Deal for Its Antibiotic

In a deal worth up to €23.6M, Summit Therapeutics licensed the commercialization of its new antibiotic ridinilazole to Eurofarma. Oxford-based Summit Therapeutics is working on new antibiotics to fight antimicrobial resistance. Its candidate ridinilazole has attracted the attention of a Brazilian pharma, Eurofarma, and the pair has made a deal for $2.5M (€2.1M) upfront and […]

December 21, 2017 - 1 minutemin - By Evelyn Warner

Best in Biotech 19 Dec 2017

Labiotech’s Favorite Biotechs: Which companies do we like and why?

We’ve already named the best companies of the year, but which are our favorite companies? Here’s who they are and why! We tried to be objective when we went through the best companies (as well as the best and worst clinical moments) of the year, but we still have our soft spots. When I asked the […]

December 19, 2017 - 4 minutesmins - By Evelyn Warner

News and Trends 12 Dec 2017

The Largest Medtech Fund in Europe is Here Thanks to This Dutch VC

LSP has closed a €280M fund, Health Economics Fund 2, that is dedicated to medtech with a focus on containing costs while delivering effective healthcare. There’s a new medtech fund in town, Health Economics Fund 2 (HEF 2), and it’s the largest in Europe. Managed by Partners Anne Portwich, Rudy Dekeyser, Fouad Azzam, Clemens van Blitterswiik, […]

December 12, 2017 - 2 minutesmins - By Evelyn Warner

More News! 5 Dec 2017

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

ChemomAb kicked off its antibody efforts as a company in 2011, and its $10M Series B has attracted none other than Peter Thiel. Israeli biotech has been attracting quite sizeable funds recently, largely those of UK investment outfit Arix Bioscience. Yesterday it was announced that Peter Theil, co-founder of PayPal and assassin of Gawker, led […]

December 5, 2017 - 2 minutesmins - By Evelyn Warner

News and Trends 5 Dec 2017

The Philippines Blocks Sanofi’s Dengue Vaccine for Safety Reasons

Following alarming research about the safety of Sanofi’s dengue vaccine, Dengvaxia, The Philippines has halted its sale, distribution and marketing “to protect the general public.” Before Sanofi Pasteur distributed its dengue vaccine, Dengvaxia, there were some concerns that it would make people sicker. Last year, researchers from top American and British institutions confirmed these suspicions […]

December 5, 2017 - 3 minutesmins - By Evelyn Warner

Best in Biotech 5 Dec 2017

Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017

Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with its year-end lists of the top things that happened this year. First up, the best biotech companies of 2017! After the doozy of 2016 for biotech and pharma, things could only get better this year — and the European industry […]

December 5, 2017 - 6 minutesmins - By Evelyn Warner

In Depth 30 Nov 2017

Will Pharma Reach a Negative Return on its R&D Investments?

It isn’t news that pharma’s business model is in trouble, but a new report from Evaluate and number crunching from Endpoints show the size of the problem. Pharma depends on innovation, which is why it turns to biotech as the powerhouse of novel technologies. About 65% of recently drugs come from small life sciences companies […]

November 30, 2017 - 3 minutesmins - By Evelyn Warner

In Depth 28 Nov 2017

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here’s a review of biotech’s progress. Biotech is arguably built on genetic medicine. When Genentech‘s insulin produced by genetically engineered bacteria kicked off biotech fever in the 1980s, the concept of directly repairing defective human DNA wasn’t […]

November 28, 2017 - 8 minutesmins - By Evelyn Warner

Interview 20 Nov 2017

Thinking of Leaving Academia? Read this VC Partner’s Story

Anne Portwich, Partner at venture capital firm LSP, told me about her career path and how to succeed in the life science industry. Anne Portwich became the first woman partner at LSP in 2011. The fund has raised more than $1B since it was founded more than 25 years ago, and the cash goes mainly to […]

November 20, 2017 - 9 minutesmins - By Evelyn Warner

topas therapeutics timm jessen interview

Interview 15 Nov 2017

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

In our last BIO Europe interview, I caught up with CEO Timm Jessen of Topas Therapeutics to hear about the company’s nanoparticles. Founded in 2013 as a spinout from Evotec, Topas Therapeutics is developing nanoparticles for a whole range of diseases and with CEO Timm Jessen at the helm. He told me the story of […]

November 15, 2017 - 4 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Evelyn Warner

About

Articles by Evelyn Warner

The Biggest Biotech News of 2017: What Happened This Year?

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

Oxford Biotech Makes a Latin American Deal for Its Antibiotic

Labiotech’s Favorite Biotechs: Which companies do we like and why?

The Largest Medtech Fund in Europe is Here Thanks to This Dutch VC

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

The Philippines Blocks Sanofi’s Dengue Vaccine for Safety Reasons

Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017

Will Pharma Reach a Negative Return on its R&D Investments?

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Thinking of Leaving Academia? Read this VC Partner’s Story

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Evelyn Warner

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!